Warmerdam P A, Long E O, Roche P A
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
J Cell Biol. 1996 Apr;133(2):281-91. doi: 10.1083/jcb.133.2.281.
Newly synthesized class II molecules of the major histocompatibility complex must be transported to endosomal compartments where antigens are processed for presentation to class II-restricted T cells. The invariant chain (Ii), which assembles with newly synthesized class II alpha- and beta-chains in the endoplasmic reticulum, carries one or more targeting signals for transport to endosomal compartments where Ii dissociates from alpha beta Ii complexes. Here we show that the transport route of alpha beta Ii complexes is regulated selectively by two forms of Ii (p33 and p35) that are generated by the use of alternative translation initiation sites. Using a novel quantitative surface arrival assay based on labeling with [6-3H]-D-galactose combined with biochemical modification at the cell surface with neuraminidase, we demonstrate that newly synthesized alpha beta Ii molecules containing the Ii-p33 isoform can be detected on the cell surface shortly after passage through the Golgi apparatus/trans-Golgi network. A substantial amount of these alpha beta Ii complexes are targeted to early endosomes either directly from the trans-Golgi network or after internalization from the cell surface before their delivery to antigen processing compartments. The fraction of alpha beta Ii complexes containing the p35 isoform of Ii with a longer cytosolic domain was not detected at the cell surface as determined by iodination of intact cells and the lack of susceptibility to neuraminidase trimming on ice. However, treatment with neuraminidase at 37 degrees C did reveal that some of the alpha beta Ii-p35 complexes traversed early endosomes. These results demonstrate that a fraction of newly synthesized class II molecules arrive at the cell surface as alpha beta Ii complexes before delivery to antigen processing compartments and that class II alpha beta Ii complexes associated with the two isoforms of Ii are sorted to these compartments by different transport routes.
新合成的主要组织相容性复合体II类分子必须转运至内体区室,抗原在此被加工处理,以呈递给受II类分子限制的T细胞。恒定链(Ii)在内质网中与新合成的II类α链和β链组装在一起,它携带一个或多个靶向信号,用于转运至内体区室,在那里Ii从αβIi复合体上解离。在此我们表明,αβIi复合体的转运途径由通过使用不同翻译起始位点产生的两种形式的Ii(p33和p35)选择性调控。使用一种基于用[6-³H]-D-半乳糖标记并结合在细胞表面用神经氨酸酶进行生化修饰的新型定量表面到达分析方法,我们证明,含有Ii-p33异构体的新合成的αβIi分子在通过高尔基体/反式高尔基体网络后不久就能在细胞表面被检测到。这些αβIi复合体中有相当一部分直接从反式高尔基体网络靶向早期内体,或者在从细胞表面内化后再被递送至抗原加工区室之前靶向早期内体。通过完整细胞碘化以及在冰上对神经氨酸酶修剪不敏感,未在细胞表面检测到含有具有较长胞质结构域的Ii的p35异构体的αβIi复合体部分。然而,在37℃用神经氨酸酶处理确实表明一些αβIi-p35复合体穿过了早期内体。这些结果表明,一部分新合成的II类分子在被递送至抗原加工区室之前以αβIi复合体的形式到达细胞表面,并且与Ii的两种异构体相关的II类αβIi复合体通过不同的转运途径被分选至这些区室。